首页> 外文OA文献 >Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.

【2h】

Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.

机译：激活Wnt /β-Catenin通路治疗黑色素瘤 - 应用LY2090314，一种新的糖原合成酶激酶-3选择性抑制剂。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Jennifer M Atkinson; Kenneth B Rank; Yi Zeng; Andrew Capen; Vipin Yadav; Jason R Manro; Thomas A Engler; Marcio Chedid;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Selective treatment of mixed-lineage leukemia leukemic stem cells through targeting glycogen synthase kinase 3 and the canonical Wnt/β2-catenin pathway [J] . FungT.K., GandilletA., SoC.W.E. Current opinion in hematology . 2012,第4期

机译：通过靶向糖原合酶激酶3和经典的Wnt /β2-catenin途径选择性治疗混合型白血病白血病干细胞
2. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs. [J] . Takahashi-Yanaga F, Sasaguri T Journal of pharmacological sciences. . 2009,第2期

机译：靶向糖原合酶激酶3β（GSK-3beta）介导的信号转导途径的药物开发：Wnt /β-catenin信号通路的抑制剂作为新型抗癌药物。
3. Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: Inhibitors of the Wnt/β-Catenin Signaling Pathway as Novel Anticancer Drugs [J] . Fumi Takahashi-Yanaga, Toshiyuki Sasaguri Journal of pharmacological sciences. . 2009,第2期

机译：靶向糖原合酶激酶3β（GSK-3β）介导的信号传导途径的药物开发：Wnt /β-Catenin信号通路的抑制剂作为新型抗癌药物
4. Sustained Delivery of Glycogen Synthase Kinase Inhibitor AR28 Is Critical for Osteogenic Selectivity in MSCs [C] . M.R. Newman, M. Ackun-Farmmer, Y. Wang, Society for Biomaterials annual meeting and exposition . 2019

机译：糖原合酶激酶抑制剂AR28的持续传递对MSCs成骨选择性至关重要
5. Regulation of the Follistatin Gene by RSPO-LGR4 Signaling via Activation of the WNT/beta-Catenin Pathway in Skeletal Myogenesis. [D] . Tan, Leonard Choon Huat. 2015

机译：通过激活骨骼肌发生中的WNT /β-Catenin途径激活RSPO-LGR4信号调节卵泡抑素基因。
6. Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314 a Novel Selective Inhibitor of Glycogen Synthase Kinase-3 [O] . Jennifer M. Atkinson, Kenneth B. Rank, Yi Zeng, -1

机译：激活Wnt /β-Catenin途径治疗黑素瘤–糖原合酶激酶3的新型选择性抑制剂LY2090314的应用
7. Glycogen synthase kinase 3 inhibitors induce the canonical WNT/ -catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma [O] . E. Y. Chen, M. T. DeRan, M. S. Ignatius, 2014

机译：糖原合成酶激酶3抑制剂诱导规范Wnt / -catenin途径，以抑制胚胎横纹肌肉瘤中的生长和自我更新

Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3.

著录项

相似文献

相关主题

期刊订阅